FVIII-Tregitope (EpiVax/Biotest)

N/A

Report date: 2025/01/26 18:49:48

Base Information

Drug NameFVIII-Tregitope (EpiVax/Biotest)
Drug Alias NameDeimmunized FVIII (EpiVax/Biotest)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCoagulation factor VIII stimulantsImmunoglobulin agonists
TargetsCoagulation factor VIIIImmunoglobulin
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEpiVax Inc
China Registration ClassN/A

Develop Information

Active CompaniesEpiVax IncBiotest Ag
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A